Bank of America’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bank of America’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,012	Closed	-$295K	–	8596
2022 Q4	$295K	Buy	24,012 +13,880	+137%	+$331K	﹤0.01%	5709
2022 Q3	$332K	Sell	10,132 -16,255	-62%	-$459K	﹤0.01%	5676
2022 Q2	$497K	Buy	26,387 +17,085	+184%	+$327K	﹤0.01%	5433
2022 Q1	$163K	Buy	+9,302	New	+$191K	﹤0.01%	6589

Bank of America's CINC Position: Q1 2023 in Review

Bank of America sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 24,012 shares — an estimated $295K sold.

Bank of America first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $497K in Q2 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Bank of America reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bank of America sold 24,012 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $295K.
Bank of America first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Bank of America's CinCor Pharma, Inc. Common Stock position peaked at $497K in Q2 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.